Connor, Clark & Lunn Investment Management (CC&L)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.7M | Sell |
|
|||||
|
2022
Q3 | $2.01M | Hold |
|
|||||
|
2022
Q2 | $1.26M | Sell |
|
|||||
|
2022
Q1 | $1.13M | Sell |
|
|||||
|
2021
Q4 | $1.05M | Sell |
|
|||||
|
2021
Q3 | $1.11M | Sell |
|
|||||
|
2021
Q2 | $1.44M | Hold |
|
|||||
|
2021
Q1 | $1.7M | Sell |
|
|||||
|
2020
Q4 | $4.32M | Sell |
|
|||||
|
2020
Q3 | $3.38M | Sell |
|
|||||
|
2020
Q2 | $3.5M | Sell |
|
|||||
|
2020
Q1 | $3.22M | Sell |
|
|||||
|
2019
Q4 | $3.44M | Hold |
|
|||||
|
2019
Q3 | $2.19M | Sell |
|
|||||
|
2019
Q2 | $4.61M | Sell |
|
|||||
|
2019
Q1 | $4.85M | Sell |
|
|||||
|
2018
Q4 | $5.29M | Sell |
|
|||||
|
2018
Q3 | $6.78M | Buy |
|
|||||
|
2018
Q2 | $6.95M | Buy |
|
|||||
|
2018
Q1 | $7.56M | Buy |
|
|||||
|
2017
Q4 | $2.58M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $402K | Sell |
|
|||||
|
2015
Q3 | $595K | Buy |
|
|||||
|
2015
Q2 | $401K | Buy |
|
|||||
|
2015
Q1 | $379K | Buy |
|
|||||
|
2014
Q4 | $180K | Buy |
|